Düsseldorf/Germany: After three fascinating and very interesting days, MEDICA 2019 ended on 21 November. Once again, the world’s leading medical trade fair was a huge success. At STORZ MEDICAL’s exhibition stand in hall 10, the full range of the company’s therapy options was on display – including several innovations. Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system, a unique procedure for patients with Alzheimer's disease, was explained in detail by Dr Rafael Storz, who also answered the visitors’ questions. In addition, the new MAGNETOLITH® for Extracorporeal Magnetotransduction Therapy (EMTT®) and the redesigned MODULITH® SLC were also at the centre of attention. Both devices were unveiled and presented during the trade fair.
In September 2020, the 100th MAGNETOLITH® was ordered and delivered to Dr Damian Görner from the Steglitz Spine and Joints Centre in Berlin. In an interview, the specialist for orthopaedics and trauma surgery explains why he decided to use MAGNETOLITH®, which indications he treats and how EMTT® and ESWT complement each other.
In February 2020, STORZ MEDICAL has received the CE approval for the MAGNETOLITH® system, which is the successor of the CELLACTOR® MT1. Extracorporeal Magnetotransduction Therapy (EMTT®) with the MAGNETOLITH® opens up new possibilities in regeneration and rehabilitation. The areas of application include diseases of the musculoskeletal system such as lower back pain and tendinopathies of the rotator cuff or Achilles tendon. The non-invasive, outpatient therapy is virtually free of side effects.
In early 2021, pro triathlete Caroline Livesey and her husband Mark headed to Costa Rica in search of a gravel cycling adventure. They embarked on a challenge to ride across the country from the Caribbean Sea to the Pacific Ocean in...
Magnetism is a central driving force in today's world, which is dominated by technology - whether on the road, rail in hospitals or in private households. Here's a crash course in everything you need to know about the wonders of magnetism...
On 3 May 2021, STORZ MEDICAL received the 510(k) clearance for the MAGNETOLITH® from the U.S. Food and Drug Administration (FDA). The therapy device is now cleared in the USA (as a class II medical device) for the following indications:
- Relaxation of muscle spasms
- Prevention or retardation of disuse atrophy
- Increase local blood circulation
- Muscle re-education
- Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis
- Maintaining or increasing range of motion